Delivery Order SPE2DB24D2205-SPE2DB25FEEUK
- Not listed
- This federal contract award, valued at $2,149.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,142,826 potassium chloride extended-release tablets, 500 tablets per bottle. The contract is not set aside and has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.40 firm fixed-price delivery order is for the supply of Potassium Chloride Extended Release 20 MEQ Tablets in 500-count bottles. The contract has an ultimate completion date of May 7, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4560815782 - Potassium Cl ER 20 MEQ Tablet 100s, with a ceiling value of $1,100.40 and a completion date of May 4, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of 4564244664 ! POTASSIUM CL ER 20 MEQ TABLET 500S to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,824.78 firm fixed price delivery order has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, delivering the pharmaceutical products to support military treatment programs and facilities. This...
- This federal contract award is for the delivery of 4,566,405,585 potassium chloride extended-release (ER) 8 milliequivalent (meq) tablets in 500-count packages. The contract, valued at $1,823.68, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,199.81, is for the delivery of potassium chloride extended-release tablets. It is a firm fixed-price delivery order contract with a period of performance through March 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
- This is a firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of a medication, Potassium Chloride Extended Release 20 MEQ Tablet, and has a ceiling value of $8,528.61. The contract does not have a set-aside designation, indicating it was open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,355.35, is for the delivery of Potassium Chloride Extended Release 8 MEQ Tablets in 500-count bottles. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp is the prime contractor and holds a larger...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the delivery of potassium chloride extended-release capsules, a critical medication for various medical conditions. The contract has a ceiling value of $3,641.65 and a completion date of September 16, 2024. There is no set-aside designation...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $3,890.35 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4563634627 - POTASSIUM CL ER 20 MEQ TABLET 500S, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEEUKDelivery Order
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,919.28. The award is not set aside and covers the supply of Potassium CL ER 10 MEQ Tablets in 500-count packages, with a period of performance through July 14, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/11/25 |